Dr Wu Skincare CoROCO:6523 -0.72%81 EBITDA Margin % is 38.29% as of Dec. 2025, which is 4% above its 10-year median of 36.78. GuruFocus rates ROCO:6523 with a GF Score™ of 81/100 and a GF Value™ of NT$151.16 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,952 Consumer Packaged Goods companies, Dr Wu Skincare Co ranks better than 96.26% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Dr Wu Skincare Co's EBITDA for the
three
months ended in Dec. 2025 was NT$105 Mil. Dr Wu Skincare Co's Revenue for the
three
months ended in Dec. 2025 was NT$275 Mil. Therefore, Dr Wu Skincare Co's EBITDA margin for the quarter that ended in Dec. 2025 was 38.29%.
Dr Wu Skincare Co (ROCO:6523) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Dr Wu Skincare Co EBITDA Margin % Related Terms
Dr Wu Skincare Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Dr Wu Skincare Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6523 vs PG, CL, KVUE: EBITDA Margin % Comparison
For the Household & Personal Products subindustry, Dr Wu Skincare Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Wu Skincare Co EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Dr Wu Skincare Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Dr Wu Skincare Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Wu Skincare Co (ROCO:6523) has a EBITDA Margin % of 38.29% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Dr Wu Skincare Co and its competitors. This is near median its historical median of 36.78. Over the past decade, Dr Wu Skincare Co's EBITDA Margin % has ranged from 8.66 to 105.68. According to the industry distribution chart, Dr Wu Skincare Co ranks #73 out of 1952 companies in the Consumer Packaged Goods industry, placing it in the top 3.7%.
Is Dr Wu Skincare Co's EBITDA Margin % too high?
Dr Wu Skincare Co's current EBITDA Margin % of 38.29% is near median its 10-year median of 36.78. Over the past 10 years, this metric has ranged from a low of 8.66 to a high of 105.68. The Consumer Packaged Goods industry median EBITDA Margin % is 8.98. Dr Wu Skincare Co's value of 38.29% is 326.4% above this industry median. Based on the distribution chart, Dr Wu Skincare Co ranks #73 out of 1952 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Dr Wu Skincare Co has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Wu Skincare Co's EBITDA Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Dr Wu Skincare Co ranks #73 out of 1952 companies for EBITDA Margin %. This places Dr Wu Skincare Co in the top 4% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 8.98. Dr Wu Skincare Co's value of 38.29% is 326.4% above this benchmark. Historically, Dr Wu Skincare Co's own EBITDA Margin % has ranged from 8.66 to 105.68 over the past decade. While the company's 10-year median is 36.78 vs. the industry median of 8.98, Dr Wu Skincare Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.98, based on 1,952 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Wu Skincare Co's current EBITDA Margin % of 38.29% is 326.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Dr Wu Skincare Co and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Wu Skincare Co's current EBITDA Margin % is 38.29%, which is near median its own 10-year median of 36.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Wu Skincare Co stock overvalued right now?
Based on GuruFocus' analysis, Dr Wu Skincare Co (ROCO:6523) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$151.16, compared to a current price of NT$97.00 — trading 35.8% below its estimated fair value. The current EBITDA Margin % is 38.29%, which is near median its 10-year median of 36.78 and 326.4% above the Consumer Packaged Goods industry median of 8.98. Dr Wu Skincare Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Dr Wu Skincare Co (ROCO:6523), the current EBITDA Margin % is 38.29% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Wu Skincare Co (ROCO:6523) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Wu Skincare Co stock appears to be undervalued.
The current stock price of NT$97.00 is trading 35.8% below its estimated GF Value™ of NT$151.16.
GuruFocus considers Dr Wu Skincare Co to be Significantly Undervalued.
Key valuation signals for ROCO:6523:
EBITDA Margin %: 38.29% (near median its 10-year median of 36.78)
GF Value™: NT$151.16 vs. price of NT$97.00 (35.8% below fair value)
Industry Position: 326.4% above the Consumer Packaged Goods median (#73 of 1952)
No single metric tells the full story. See the ROCO:6523 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Wu Skincare Co Ltd is a Taiwan based company engaged in the research, development, production, wholesale and retail of cosmetics. It principally manufactures and sells cosmetics. The company offers products such as cosmetic masks, lotions, eye care products, moisturizers and others. The group derives its revenue from the sales of private label care products. It sells the products in Taiwan and internationally, of which majority of the revenue is derived from the sales made in Taiwan.
81GF Score
Get the complete analysis for ROCO:6523
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6523 has been successfully added to your 
